HOB Biotech Group Corp Ltd (688656) — Capital Reinvestment Ratio
Latest as of December 2025:
0.56x
HOB Biotech Group Corp Ltd (688656) has a Capital Reinvestment Ratio of 0.56x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥15.28 Million) in capital expenditures (CN¥8.50 Million). See 688656 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.56x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥15.28 Million
CNY
Capital Expenditures
CN¥8.50 Million
CNY
Data as of
Dec 2025
Most recent filing
HOB Biotech Group Corp Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks HOB Biotech Group Corp Ltd's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for HOB Biotech Group Corp Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for HOB Biotech Group Corp Ltd from 2016 to 2025. For live market cap and broader valuation context, see HOB Biotech Group Corp Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.01x | CN¥72.94 Million | CN¥73.90 Million | ▼ -34.0% |
| 2024 | 1.53x | CN¥101.22 Million | CN¥155.37 Million | ▼ -11.5% |
| 2023 | 1.73x | CN¥102.69 Million | CN¥178.03 Million | ▼ -54.1% |
| 2022 | 3.78x | CN¥58.31 Million | CN¥220.21 Million | ▲ +135.7% |
| 2021 | 1.60x | CN¥104.79 Million | CN¥167.89 Million | ▲ +63.6% |
| 2020 | 0.98x | CN¥58.22 Million | CN¥57.01 Million | ▲ +93.0% |
| 2019 | 0.51x | CN¥68.57 Million | CN¥34.80 Million | ▼ -11.5% |
| 2018 | 0.57x | CN¥46.51 Million | CN¥26.66 Million | ▼ -38.7% |
| 2017 | 0.94x | CN¥22.26 Million | CN¥20.82 Million | ▼ -65.0% |
| 2016 | 2.67x | CN¥6.42 Million | CN¥17.15 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow